Mithra Pharmaceuticals SA announced that it will receive 3,871,500 shares at a price of 6.07 per share for gross proceeds of 23,500,000 on June 21, 2022. The transaction will include participation from professional, institutional and private investors, including Leon Van Rompaey, Chief Executive Officer for 3,900,000 shares. Issue price of 6.07 per share, representing a 5% discount to closing share price.
The company will issue equity in the transaction. The transaction is expected to be completed on or about June 24, 2022.